DENVER, Colo., 21 May, 2024 (247marketnews.com)- Mangoceuticals, Inc. (NASDAQ:MGRX) announced an exhilarating development in the stock market with its shares soaring to $0.51 in the pre-market session, a significant leap from the previous close of $0.253. The remarkable trading volume of 15.4M shares is a clear indication of the bullish trend and investor confidence in the company, showcasing a staggering 101.7% change as the market anticipates further growth.
Simultaneously, MangoRx proudly reveals the introduction of two revolutionary oral dissolvable tablets (ODTs) by the names of “Slim” and “Trim”, representing the seminal transformation of Semaglutide and Tirzepatide respectively.
This catalytic announcement has galvanized the investor community, with the stock’s upsurge a testament to the potential impact of “Slim” and “Trim” on MangoRx’s market position. The company’s innovative approach to health and wellness primes it for potentially becoming a dominant force in the burgeoning weight management sector
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (MGRX)
- 24/7 Market News Snapshot 27 May, 2025 – Mangoceuticals, Inc. Common Stock (NASDAQ:MGRX)
- Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu
- CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector
- ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector
- 24/7 Market News Snapshot 25 April, 2025 – Mangoceuticals, Inc. Common Stock (NASDAQ:MGRX)